Stockreport

EXCLUSIVE: Vivani Medical Initiates First Human Clinical Trial With GLP-1 Implant For Weight Loss In Australia [Yahoo! Finance]

Vivani Medical, Inc.  (VANI) 
PDF On Thursday, Vivani Medical Inc. (NASDAQ: VANI ) initiated screening and enrollment at two centers in Australia for the first-in-human clinical trial, LIBERATE-1. The [Read more]